Nuclear medicine applications in molecular imaging: 2007 update.

Q J Nucl Med Mol Imaging

Division of Pediatric Radiology, F.G.B.-Department of Radiology, Lucile Salter Packard Children's Hospital, Stanford, CA, USA.

Published: June 2007

AI Article Synopsis

  • The review covers different types of radiolabeled agents that target specific receptors like somatostatin, benzodiazepine, and dopamine; as well as hormones like progesterone and estrogen.
  • It highlights agents that can locate areas of low oxygen (hypoxia) and discusses their effectiveness in identifying angiogenesis (formation of new blood vessels) and inflammation.
  • Finally, the review assesses the current clinical use of these agents and their potential benefits for diagnosis and treatment in medicine.

Article Abstract

This review examines several classes of radiolabeled agents, including analogs localizing in somatostatin, benzodiazepine and dopamine receptors; analogs of progesterone and estrogen; and agents localizing in lesions with hypoxia. It concludes the status of agents advocated for detecting angiogenesis and inflammation. The current clinical status of these agents, and their potential roles in diagnosis and treatment are discussed.

Download full-text PDF

Source

Publication Analysis

Top Keywords

status agents
8
nuclear medicine
4
medicine applications
4
applications molecular
4
molecular imaging
4
imaging 2007
4
2007 update
4
update review
4
review examines
4
examines classes
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!